Fri 29 March 2024
Warszawa (PL)
16/7°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
18 |
16 |
23 |
22 |
24 |
Fri 29 March 2024
Praha (CZ)
18/5°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
17 |
20 |
25 |
21 |
17 |
Fri 29 March 2024
Bratislava (SK)
20/5°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
16 |
20 |
23 |
23 |
20 |
Fri 29 March 2024
Budapest (HU)
19/3°C
Thu
|
Fri
|
Sat
|
Sun
|
Mon
|
15 |
21 |
24 |
22 |
24 |
February 16th, 2021
The Czech State Drugs Control Institute (SUKL) recommended an anti-coronavirus drug by the Regeneron company to be used in Czechia even though it has not been registered yet, SUKL director Irena Storova tweeted today. The drug is based on a combination of two monoclonal antibodies, Casirivimab and Imdevimab. It is meant for high-risk outpatients. A week ago, the SUKL recommended the first monoclonal-based drug from the U.S. Eli Lilly firm and its usage was approved by the Health Ministry, too, some days after.
CTK
Pageviews this month:
43,329